Another in vitro study suggested that AML cells protect themselves by producing soluble TIM-3 to form a TIM-3-galectin-9 complex that attenuates NK cell-mediated cytotoxicity [39]. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.